BNGO - Bionano Genomics Inc
Bionano Genomics Inc Logo

BNGO - Bionano Genomics Inc

https://bionano.com
Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

Bionano Genomics, Inc. is a life science instrumentation company in the genome analysis space. The company is headquartered in San Diego, California.

52W High
$30.52
52W Low
$2.68

MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
2.26
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-0.18
EV/Revenue (<3 favorable)
0.80
P/S (TTM) (<3 favorable)
0.68
P/B (<3 favorable)
0.41
Ownership
Retail‑heavy
Source: Overview
Insiders (1–5% typical)
0.05%
Institutions (25–75% balanced)
2.15%
Shares Outstanding
4,681,000
Float
4,678,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
27,426,000
Gross Profit (TTM)
1,388,000
EPS (TTM)
-43.87
Profit Margin (>10% good)
-2.71%
Operating Margin (TTM) (higher better)
-1.16%
ROE (TTM) (>15% strong)
-1.18%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
-0.13
Momentum
Bearish momentum
Value
0.3185
Previous
0.3553
Trend
Falling
Signal Cross
No cross

As of
Sep. 11, 2025